Corton Capital Inc. Arcellx, Inc. Transaction History

Corton Capital Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$49.74 - $66.98 $157,078 - $211,522	3,158 Added 101.38%	6,273 $346,000
Q1 2024 May 15, 2024	SELL	$51.85 - $73.49 $273,975 - $388,321	-5,284 Reduced 62.91%	3,115 $216,000
Q4 2023 Feb 14, 2024	BUY	$31.75 - $57.99 $27,495 - $50,219	866 Added 11.5%	8,399 $466,000
Q3 2023 Nov 14, 2023	BUY	$31.51 - $37.4 $237,364 - $281,734	7,533 New	7,533 $270,000

205

44.1M

2.23M

907K

Ticker ACLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,819,200
Market Cap $2.94B
Description
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Corton Capital Inc. with notifications on news.